Medipattern's B-CADTM Version 2 Shown To Increase Diagnostic Accuracy By 44% In Lesions Less Than 1 Cm In Size

The Medipattern Corporation (TSX VENTURE:MKI), an award-winning developer of computer-aided detection (CAD) medical imaging software designed to aid physicians in making better informed biopsy decisions and to permit a higher standard of care for the millions of patients at risk of cancer, is pleased to announce the publication of a study showing a significant increase in diagnostic accuracy when using B-CAD v2 on lesions less than 1 cm in size (B-CAD v2 is only available outside the United States).

The study was conducted at the PLA301 Hospital in Beijing, PRC and is based upon 100 confirmed biopsied cases, comparing the diagnostic accuracy of three reading scenarios: a single physician, double reading with two physicians and a single physician reading with B-CAD. The accuracy of the single physician increased with B-CAD in all categories. The most striking result shows a statistically significant 44 percent improvement in diagnostic accuracy for the single reader with B-CAD v2 on lesions less than 1 cm in size (n equals 9).

"The Value of Computer-Aided Detection for Breast Ultra-Sonography (B-CAD) in the Diagnosis of Breast Cancer" by Dr. Li and Dr. Xu will be shared at the 18th annual conference of the National Consortium of Breast Centers (NCBC) which takes place March 1 to March 5, 2008 in Las Vegas.

For further information visit MediPattern